MSR15 Psychometric Validation of the Electronic Hidradenitis Suppurativa (HS) Symptom Daily Diary (eHSSDD) and Electronic HS Symptom Questionnaire (eHSSQ) Using Data from the Phase 3 BE HEARD Trials of Bimekizumab in HS
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.1551
https://www.valueinhealthjournal.com/article/S1098-3015(23)01651-0/fulltext
Title :
MSR15 Psychometric Validation of the Electronic Hidradenitis Suppurativa (HS) Symptom Daily Diary (eHSSDD) and Electronic HS Symptom Questionnaire (eHSSQ) Using Data from the Phase 3 BE HEARD Trials of Bimekizumab in HS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)01651-0&doi=10.1016/j.jval.2023.03.1551
First page :
Section Title :
Open access? :
No
Section Order :
10948